Filters

Dopamine Receptor D1 Antibody , PE Conjugated

Dopamine Receptor D1 Antibody , PE Conjugated size: 0.1ml 368

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 368
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name PE Conjugated, Dopamine Receptor D1 Antibody
CategoryConjugated Primary Antibodies
ConjugationPE
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenDopamine Receptor D1
SpecificityThis is a highly specific antibody against Dopamine Receptor D1
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range2-23/446
Subcellular location Cell membrane, Extracellular
SourceKLH conjugated synthetic peptide derived from human Dopamine Receptor D1
Gene ID number1812
Swiss ProtP21728
Tested applicationsFCM
Recommended dilutionsFCM(1:20-100)
CrossreactivityHuman
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen backgroundDopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission480, 565nm/578nm
Synonyms D(1A) dopamine receptor, DRD1, DRD1A, Dopamine D1 receptor, DADR
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetDopamine Receptor D1 PE Conjugated
Short nameDopamine Receptor D1 Antibody PE Conjugated
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelPE
Alternative name peroxidase coupled, Dopamine Receptor D1 (Antibody to)
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter